Skip to content
10-Q

Quarterly Report

NASCENT BIOTECH, INC.

0001477932-24-000722

← back to feed
Filed
Feb 14, 2024 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Feb 14, 2024 169.73M sh
Operating Cash Flow Q3 2024 · Dec 31, 2023 −$834.33K
Operating Cash Flow Q3 2024 · Dec 31, 2022 −$1.4M
Stockholders Equity Q3 2024 · Dec 31, 2023 $30.37K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$6.41K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$1.12M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$1.3M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$1.36M
Stockholders Equity Q3 2024 · Sep 30, 2022 −$1.19M
Stockholders Equity Q3 2024 · Jun 30, 2022 −$1.44M
Stockholders Equity Q3 2024 · Mar 31, 2022 −$671.48K
Current Liabilities Q3 2024 · Dec 31, 2023 $610.93K
Current Liabilities Q3 2024 · Mar 31, 2023 $1.55M
Total Liabilities Q3 2024 · Dec 31, 2023 $610.93K
Total Liabilities Q3 2024 · Mar 31, 2023 $1.55M
Current Assets Q3 2024 · Dec 31, 2023 $641.7K
Current Assets Q3 2024 · Mar 31, 2023 $255K
Total Assets Q3 2024 · Dec 31, 2023 $641.3K
Total Assets Q3 2024 · Mar 31, 2023 $255K
Rd Expense Q3 2024 · Dec 31, 2023 $47.17K
Rd Expense Q3 2024 · Dec 31, 2023 $101.39K
Rd Expense Q3 2024 · Dec 31, 2022 $55.88K
Rd Expense Q3 2024 · Dec 31, 2022 $188.5K
Net Income Q3 2024 · Dec 31, 2023 −$205.41K
Net Income Q3 2024 · Dec 31, 2023 −$1.58M
Net Income Q3 2024 · Sep 30, 2023 −$829.48K
Net Income Q3 2024 · Jun 30, 2023 −$540.22K
Net Income Q3 2024 · Dec 31, 2022 −$837.32K
Net Income Q3 2024 · Dec 31, 2022 −$2.28M
Net Income Q3 2024 · Sep 30, 2022 −$145.71K
Net Income Q3 2024 · Jun 30, 2022 −$1.3M
Operating Income Q3 2024 · Dec 31, 2023 −$364.42K
Operating Income Q3 2024 · Dec 31, 2023 −$1.71M
Operating Income Q3 2024 · Dec 31, 2022 −$475.03K
Operating Income Q3 2024 · Dec 31, 2022 −$1.62M